References:
1. Vano LJ, McCutcheon RA, Rutigliano G, et al. Mesostriatal dopaminergic circuit dysfunction in schizophrenia: a multimodal neuromelanin-sensitive magnetic resonance imaging and [18F]-DOPA positron emission tomography study. Biol Psychiatry 2024; 96: 674–683.
2. Abi-Dargham A, Gil R, Krystal J, et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry. 1998; 155: 761–767.
3. Katthagen T, Kaminski J, Heinz A, et al. Striatal dopamine and reward prediction error signaling in unmedicated schizophrenia patients. Schizophr Bull 2020; 46: 1535–1546.
4. Howes OD, Kambeitz J, Kim E, et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 2012; 69: 776–786.
5. McCutcheon R, Beck K, Jauhar S, et al. Defining the locus of dopaminergic dysfunction in schizophrenia: a meta-analysis and test of the mesolimbic hypothesis. Schizophr Bull 2018; 44: 1301–1311.
6. Slifstein M, van de Giessen E, Van Snellenberg J, et al. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry 2015; 72: 316–324.
7. Rao N, Northoff G, Tagore A, et al. Impaired prefrontal cortical dopamine release in schizophrenia during a cognitive task: A [11C]FLB 457 positron emission tomography study. Schizophr Bull 2019; 45: 670–679.
8. Frankle WG, Himes M, Mason NS, et al. Prefrontal and striatal dopamine release are inversely correlated in schizophrenia. Biol Psychiatry 2022; 92: 791–799.